Gregory C Fanning

Title: Innovations of Gregory C. Fanning in Gene Therapy

Introduction

Gregory C. Fanning is a notable inventor based in Bronte, Australia. He has made significant contributions to the field of gene therapy, particularly in the modification of hematopoietic progenitor cells. With a total of two patents to his name, Fanning's work is paving the way for advancements in medical treatments.

Latest Patents

Fanning's latest patents focus on methods for genetic modification of hematopoietic progenitor cells and their uses. These patents describe compositions and methods related to gene therapy, specifically applied to hematopoietic progenitor (HP) cells. The inventions detail methods of obtaining transduced cells and using them to provide prolonged engraftment of modified hematopoietic cells in human subjects. Notably, these innovations are aimed at the treatment or prevention of HIV infection through ex vivo gene therapy of HP cells.

Career Highlights

Gregory C. Fanning is currently associated with Johnson & Johnson Research Pty Limited, where he continues to develop groundbreaking technologies in the field of gene therapy. His work is instrumental in advancing therapeutic options for patients with hematological conditions.

Collaborations

Fanning has collaborated with esteemed colleagues such as Geoffrey Phillip Symonds and Rafael G. Amado. These partnerships enhance the research and development efforts in the field of gene therapy.

Conclusion

Gregory C. Fanning's contributions to gene therapy represent a significant advancement in medical science. His innovative approaches to modifying hematopoietic progenitor cells are crucial for developing effective treatments for serious health conditions.